• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • US FDA approves Siliq to treat plaque psoriasis pharmaceutical-technology
    February 17, 2017
    FDA Center for Drug Evaluation and Research Office of Drug Evaluation III director Julie Beitz said: "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today’s approval provides patients with anothe

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service